Home Details
| Official Symbol of Gene | MS4A1 |
| Species | Homo sapiens |
| Entrez Gene ID | 931 |
| Official Full Name | membrane spanning 4-domains A1 |
| Also known as | B1; S7; Bp35; CD20; FMC7; CVID5; LEU-16 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000156738 MIM:112210; AllianceGenome:HGNC:7315 |
| Map Location | 11q12.2 |
| Drug | rituximab |
| Interaction Type | inhibitor |
| Descent | RRMS |
| Disease | MS |
| Pubmed ID | 21155688 |
| Year | 2011 |
| Title | Antibodies against CD20 (rituximab) for treating multiple sclerosis: US20100233121 |
| Result | Future studies will involve the administration of antibodies against CD20 by gene therapy and studying and characterizing the administration of multiples drugs, in combination rituximab, for treating MS. |
| Mechanism/pathway | Rituximab depletes peripheral B cells and reduces the level of B cells in the cerebrospinal fluid of patients with relapsing-remitting MS. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.